B-Cell Acute Lymphoblastic Leukemia Associated with Set-Nup214 Rearrangement: A Case Report and Review of the Literature

Hong-Hu Zhu,Xiao-Su Zhao,Ya-Zhen Qin,Yue-Yun Lai,Hao Jiang
DOI: https://doi.org/10.3892/ol.2016.4260
2016-01-01
Oncology Letters
Abstract:The SET nuclear proto-oncogene (SET)-nucleoporin (NUP)214 fusion gene, which results from cryptic t(9;9)(q34;q34) or del(9)(q34.11q34.13), is a rare genetic event in hematological malignancies. The majority of patients carrying SET-NUP214 experience T-cell acute lymphoblastic leukemia (T-ALL), but rarely experience acute undifferentiated leukemia or acute myeloid leukemia. The current study presents the case of a 19-year-old male patient with B-cell ALL (B-ALL) carrying the SET-NUP214 fusion gene, in addition to an fms-related tyrosine kinase 3-internal tandem duplication mutation and a complex karyotype abnormality. The patient exhibited chemotherapy resistance. To the best of our knowledge, the present study is the first report of a case of B-ALL carrying the SET-NUP214 fusion gene, and provides a review of the literature.
What problem does this paper attempt to address?